The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2016
Filed:
Apr. 24, 2013
Applicant:
Cibiem, Inc., Los Altos, CA (US);
Inventors:
Mark Gelfand, New York, NY (US);
Howard Levin, Teaneck, NJ (US);
Charles Lennox, Hudson, NH (US);
Marat Fudim, Duesseldorf, DE;
Zoar Jacob Engelman, Salt Lake City, UT (US);
Martin M. Grasse, San Francisco, CA (US);
Brett Schleicher, San Francisco, CA (US);
Assignee:
CIBIEM, INC., Los Altos, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 18/18 (2006.01); A61B 18/00 (2006.01); A61B 18/02 (2006.01);
U.S. Cl.
CPC ...
A61B 18/1492 (2013.01); A61B 18/18 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00279 (2013.01); A61B 2018/00285 (2013.01); A61B 2018/00291 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/0225 (2013.01); A61B 2018/1407 (2013.01); A61B 2018/1425 (2013.01); A61B 2018/1475 (2013.01);
Abstract
Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.